XTLB
XTL Biopharmaceuticals
XTLB
XTLB
4 hedge funds and large institutions have $208K invested in XTL Biopharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$14K |
| 2 |
2
Morgan Stanley
New York
|
$52K |
| 3 |
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$85K |
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $85K | 41,791 | +1,112 | +3% |
|
2
Invesco
Atlanta,
Georgia
| $57K | 25,961 | – | – |
|
|
3
Morgan Stanley
New York
| $52K | 23,532 | +3,371 | +17% |
|
|
4
UBS Group
Zurich,
Switzerland
| $14K | 6,455 | +5,763 | +833% |
|
|
5
Citadel Advisors
Miami,
Florida
| – | – | -17,312 | Closed |
|
|
CFGS
6
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|